COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The AHA has received $6 million in grants from the Centers for Disease Control and Prevention to promote clinician and public confidence in COVID-19 vaccines, and help train current and future health care personnel to prevent and control infectious disease.
Data submitted to the Food and Drug Administration confirms that Johnson & Johnson’s COVID-19 vaccine candidate is safe and effective.
Safety monitoring during the first month of the COVID-19 national vaccination program shows “reassuring safety profiles” for the Pfizer and Moderna COVID-19 vaccines, the Centers for Disease Control and Prevention reported.
The Centers for Medicare & Medicaid Services extended until March 22 its guidance limiting the hospital survey process during the COVID-19 public health emergency.
CDC lifts COVID-19 quarantine requirement for fully vaccinated individuals outside health care. Get the latest guidance on quarantine for vaccinated individuals.
A report released by the Centers for Disease Control and Prevention highlights the importance of good fit to maximize mask performance.
The Food and Drug Administration authorized administering the monoclonal antibodies bamlanivimab and etesevimab together to treat patients 12 and older with mild-to-moderate COVID-19 who are at high risk for progressing to severe disease but not hospitalized or on oxygen therapy.
An estimated 68% of U.S. adults intended to receive a COVID-19 vaccine when surveyed by the Centers for Disease Control and Prevention in December, up from 61.9% in September.
The Food and Drug Administration issued updated guidance on using ventilator splitters to support more than one patient when other options are unavailable.
Lesbian, gay and bisexual persons in the U.S. have higher self-reported prevalence of several underlying health conditions associated with severe COVID-19 outcomes, compared to heterosexual persons, according to a Centers for Disease Control and Prevention study.